‘Unprecedented’ EMA Response To COVID-19 Must Be Sustained

Post Approval Setting Matters Too, Says New Agency Head Emer Cooke

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".